{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:57:02Z","timestamp":1791928622066,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Crohn\u2019s disease (CD) and ulcerative colitis (UC) have different immunological mechanisms, while both of them are potential targets of vitamin D treatment. In this study, we have tried to address the role of vitamin D in CD and UC using two mouse models. Mice of C57B6L were given vitamin D before the induction of colitis. Our results showed that vitamin D attenuated 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis but not oxazolone-induced colitis. Vitamin D could preserve the local histology, alleviate inflammation, suppress apoptosis, maintain tight junction function and decrease permeability. Interestingly, it has more of an effect on local structure preservation and inflammation inhibition in CD than in UC mice. Vitamin D blocked the increase of helper T-cell type 1 (Th1)- and helper T-cell type 17 (Th17)-related cytokines in TNBS-induced colitis. But the increase of helper T-cell type 2 (Th2)- and regulatory T cells (Treg)-related cytokines was augmented at the same time in oxazolone-induced colitis which counteracted each other. Our study helps elucidate the differential protective effects of vitamin D on CD and UC patients, as reported in literature.<\/jats:p>","DOI":"10.1038\/srep32889","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T12:25:43Z","timestamp":1473769543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Vitamin D treatment attenuates 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis but not oxazolone-induced colitis"],"prefix":"10.1038","volume":"6","author":[{"given":"Tianjing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"key":"BFsrep32889_CR1","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham, C. & Cho, J. H. Inflammatory bowel disease. N Engl J Med 361, 2066\u201378 (2009).","journal-title":"N Engl J Med"},{"key":"BFsrep32889_CR2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.157.3.1261","volume":"157","author":"IJ Fuss","year":"1996","unstructured":"Fuss, I. J. et al. Disparate CD4 lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn\u2019s disease LP cells manifest increased secretion of IFN-\u03b3, whereas ulcerative colitis LP cells increased secretion of IL-5. J Immunol. 157, 1261\u201370 (1996).","journal-title":"J Immunol"},{"key":"BFsrep32889_CR3","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0016-5085(97)70128-8","volume":"112","author":"G Monteleone","year":"1997","unstructured":"Monteleone, G. et al. Interleukin 12 is expressed and actively released by Crohn\u2019s disease intestinal lamina propria mononuclear cells. Gastroenterology 112, 1169\u201378 (1997).","journal-title":"Gastroenterology"},{"key":"BFsrep32889_CR4","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/ibd.21248","volume":"16","author":"M Sarra","year":"2010","unstructured":"Sarra, M., Pallone, F., Macdonald, T. T. & Monteleone, G. IL-23\/IL-17 axis in IBD. Inflamm Bowel Dis. 16, 1808\u201313 (2010).","journal-title":"Inflamm Bowel Dis"},{"key":"BFsrep32889_CR5","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI21404","volume":"116","author":"D Yen","year":"2006","unstructured":"Yen, D. et al. IL-23 is essential for T cell mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 116, 1310\u20136 (2006).","journal-title":"J Clin Invest"},{"key":"BFsrep32889_CR6","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1172\/JCI19836","volume":"113","author":"IJ Fuss","year":"2004","unstructured":"Fuss, I. J. et al. Non classical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest. 113, 1490\u20137 (2004).","journal-title":"J Clin Invest"},{"key":"BFsrep32889_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","volume":"129","author":"F Heller","year":"2005","unstructured":"Heller, F. et al. Interleukine-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129, 550\u201364 (2005).","journal-title":"Gastroenterology"},{"key":"BFsrep32889_CR8","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/153537020422901108","volume":"229","author":"MT Cantorna","year":"2004","unstructured":"Cantorna, M. T. & Mahon, B. D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med. 229, 1136\u201342 (2004).","journal-title":"Exp Biol Med."},{"key":"BFsrep32889_CR9","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1177\/1535370214523890","volume":"239","author":"MT Cantorna","year":"2014","unstructured":"Cantorna, M. T., McDaniel, K., Bora, S., Chen, J. & James, J. Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease. Exp Biol Med. 239, 1524\u201330 (2014).","journal-title":"Exp Biol Med."},{"key":"BFsrep32889_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/1751-2980.12118","volume":"15","author":"B Tan","year":"2014","unstructured":"Tan, B. et al. Vitamin D Levels and bone metabolism in Chinese adult patients with inflammatory bowel disease. J Dig Dis. 15, 116\u201323 (2014).","journal-title":"J Dig Dis."},{"key":"BFsrep32889_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s10620-010-1544-3","volume":"56","author":"AD Levin","year":"2011","unstructured":"Levin A. D. et al. Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci. 56, 830\u20136 (2011).","journal-title":"Dig Dis Sci."},{"key":"BFsrep32889_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.gastro.2011.11.040","volume":"142","author":"AN Ananthakrishnan","year":"2012","unstructured":"Ananthakrishnan, A. N. et al. Higher predicted vitamin D status is associated with reduced risk of Crohn\u2019s disease. Gastroenterology. 142, 482\u20139 (2012).","journal-title":"Gastroenterology"},{"key":"BFsrep32889_CR13","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1136\/gut.26.11.1197","volume":"26","author":"AD Harries","year":"1985","unstructured":"Harries, A. D. et al. Vitamin D status in Crohn\u2019s disease: association with nutrition and disease activity. Gut. 26, 1197\u2013203 (1985).","journal-title":"Gut."},{"key":"BFsrep32889_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ibd.22966","volume":"19","author":"LN Xue","year":"2013","unstructured":"Xue, L. N. et al. Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn\u2019s disease: a meta-analysis. Inflamm Bowel Dis. 19, 54\u201360 (2013).","journal-title":"Inflamm Bowel Dis."},{"key":"BFsrep32889_CR15","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1084\/jem.182.5.1281","volume":"182","author":"MF Neurath","year":"1995","unstructured":"Neurath, M. F., Fuss, I., Kelsall, B. L., St\u00fcber, E. & Strober, W. Antibodies to interleukin-12 abrogate established experimental colitis in mice. J Exp Med. 182, 1281\u201390 (1995).","journal-title":"J Exp Med."},{"key":"BFsrep32889_CR16","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1084\/jem.188.10.1929","volume":"188","author":"M Boirivant","year":"1998","unstructured":"Boirivant, M., Fuss, I. J., Chu, A. & Strober, W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med. 188, 1929\u201339 (1998).","journal-title":"J Exp Med."},{"key":"BFsrep32889_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1074-7613(02)00453-3","volume":"17","author":"F Heller","year":"2002","unstructured":"Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S. & Strober, W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity. 17, 629\u201338 (2002).","journal-title":"Immunity"},{"key":"BFsrep32889_CR18","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1172\/JCI65842","volume":"123","author":"W Liu","year":"2013","unstructured":"Liu, W. et al. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest. 123, 3983\u201396 (2013).","journal-title":"J Clin Invest."},{"key":"BFsrep32889_CR19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1124\/jpet.106.107599","volume":"319","author":"C Daniel","year":"2006","unstructured":"Daniel, C. et al. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice. J Pharmacol Exp Ther. 319, 622\u201331 (2006).","journal-title":"J Pharmacol Exp Ther."},{"key":"BFsrep32889_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1124\/jpet.107.127209","volume":"324","author":"C Daniel","year":"2008","unstructured":"Daniel, C., Sartory, N. A., Zahn, N., Radeke, H. H. & Stein, J. M. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1\/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 324, 23\u201333 (2008).","journal-title":"J Pharmacol Exp Ther."},{"key":"BFsrep32889_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/apt.12553","volume":"39","author":"VP Mouli","year":"2014","unstructured":"Mouli, V. P. & Ananthakrishnan, A. N. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 39, 125\u201336 (2014).","journal-title":"Aliment Pharmacol Ther."},{"key":"BFsrep32889_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2036.2010.04355.x","volume":"32","author":"SP J\u00f8rgensen","year":"2010","unstructured":"J\u00f8rgensen, S. P. et al. Clinical trial: vitamin D3 treatment in Crohn\u2019s disease \u2013 a randomized double-blind placebo controlled study. Aliment Pharmacol Ther. 32, 377\u201383 (2010).","journal-title":"Aliment Pharmacol Ther."},{"key":"BFsrep32889_CR23","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1038\/ctg.2013.1","volume":"4","author":"L Yang","year":"2013","unstructured":"Yang, L. et al. Therapeutic effect of vitamin D supplementation in a pilot study of Crohn\u2019s patients. Clin Transl Gastroenterol. 4, e33 (2013).","journal-title":"Clin Transl Gastroenterol"},{"key":"BFsrep32889_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2172-8-5","volume":"8","author":"M Froicu","year":"2007","unstructured":"Froicu, M. & Cantorna, M. T. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 8, 5\u201315 (2007).","journal-title":"BMC Immunol"},{"key":"BFsrep32889_CR25","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1210\/me.2003-0281","volume":"17","author":"M Froicu","year":"2003","unstructured":"Froicu, M. et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 17, 2386\u201392 (2003).","journal-title":"Mol Endocrinol"},{"key":"BFsrep32889_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.crohns.2012.01.007","volume":"6","author":"I Nicholson","year":"2012","unstructured":"Nicholson I., Dalzell A. M. & El-Matary W. Vitamin D as a therapy for colitis: a systematic review. J Crohns Colitis 6, 405\u201311 (2012).","journal-title":"J Crohns Colitis"},{"key":"BFsrep32889_CR27","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/imm.12319","volume":"143","author":"MT Kasaian","year":"2014","unstructured":"Kasaian, M. T. et al. Therapeutic activity of an interleukin-4\/interleukin-13 dual antagonist on oxazolone-induced colitis in mice. Immunology 143, 416\u201327 (2014).","journal-title":"Immunology"},{"key":"BFsrep32889_CR28","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.2174\/13894501113149990170","volume":"14","author":"M Jovani","year":"2013","unstructured":"Jovani, M., Fiorino, G. & Danese, S. Anti-IL-13 in inflammatory bowel disease: from the bench to the bedside. Curr Drug Targets 14, 1444\u201352 (2013).","journal-title":"Curr Drug Targets"},{"key":"BFsrep32889_CR29","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.4049\/jimmunol.173.5.3432","volume":"173","author":"A Wittke","year":"2004","unstructured":"Wittke, A., Weaver, V., Mahon, B. D., August, A. & Cantorna, M. T. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J Immunol. 173, 3432\u20136 (2004).","journal-title":"J Immunol."},{"key":"BFsrep32889_CR30","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1210\/en.2008-0078","volume":"149","author":"E Borgogni","year":"2008","unstructured":"Borgogni, E. et al. Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology. 149, 3626\u201334 (2008).","journal-title":"Endocrinology"},{"key":"BFsrep32889_CR31","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/brain\/awp033","volume":"132","author":"J Correale","year":"2009","unstructured":"Correale, J., Ysrraelit, M. C. & Gait\u00e1n, M. I. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 132, 1146\u201360 (2009).","journal-title":"Brain"},{"key":"BFsrep32889_CR32","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nm851","volume":"9","author":"O Akbari","year":"2003","unstructured":"Akbari, O. et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med. 9, 582\u20138 (2003).","journal-title":"Nat Med."},{"key":"BFsrep32889_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1017\/S0029665111003193","volume":"71","author":"MT Cantorna","year":"2012","unstructured":"Cantorna, M. T., Zhao, J. & Yang, L. Vitamin D, invariant natural killer T-cells and experimental autoimmune disease. Proc Nutr Soc. 71, 62\u20136 (2012).","journal-title":"Proc Nutr Soc."},{"key":"BFsrep32889_CR34","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1073\/pnas.0711558105","volume":"105","author":"S Yu","year":"2008","unstructured":"Yu, S. & Cantorna, M. T. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci USA 105, 5207\u201312 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep32889_CR35","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/gut.38.4.568","volume":"38","author":"JD Butzner","year":"1996","unstructured":"Butzner, J. D., Parmar, R., Bell, C. J. & Dalal, V. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut. 38, 568\u201373 (1996).","journal-title":"Gut"},{"key":"BFsrep32889_CR36","first-page":"238","volume":"69","author":"HS Cooper","year":"1993","unstructured":"Cooper, H. S., Murthy, S. N., Shah, R. S. & Sedergran, D. J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 69, 238\u201349 (1993).","journal-title":"Lab Invest."},{"key":"BFsrep32889_CR37","doi-asserted-by":"publisher","first-page":"G119","DOI":"10.1152\/ajpgi.1995.269.1.G119","volume":"269","author":"CB Appleyard","year":"1995","unstructured":"Appleyard, C. B. & Wallace, J. L. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol Gastrointest Liver Physiol. 269, G119\u201325 (1995).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFsrep32889_CR38","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1097\/MIB.0000000000000526","volume":"21","author":"J Du","year":"2015","unstructured":"Du, J. et al. 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway. Inflamm Bowel Dis. 21, 2495\u2013506 (2015).","journal-title":"Inflamm Bowel Dis"},{"key":"BFsrep32889_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1053\/j.gastro.2013.04.011","volume":"145","author":"L Su","year":"2013","unstructured":"Su, L. et al. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 145, 407\u201315 (2013).","journal-title":"Gastroenterology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep32889.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32889","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32889.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T01:45:40Z","timestamp":1672883140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep32889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep32889"],"URL":"https:\/\/doi.org\/10.1038\/srep32889","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,13]]},"assertion":[{"value":"21 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32889"}}